首页> 外文期刊>Vaccine >Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study
【24h】

Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study

机译:斯洛文尼亚妇女的高危型人乳头瘤病毒(HPV)疫苗接种前患病率和分布:基于宫颈癌筛查的研究

获取原文
获取原文并翻译 | 示例
           

摘要

To estimate the pre-vaccination prevalence of cervical infections with 14 high-risk human papillomavirus (hr-HPV) types among 20-64 years old Slovenian women screened for cervical cancer in 2010, we consecutively enrolled 4431 women in 16 outpatient gynaecology services. All were screened with Digene Hybrid Capture 2 HPV DNA Test and Abbott Real Time High Risk HPV Test and all positive specimens genotyped. Prevalence of cervical infection with any hr-HPV type examined was 12.9% with HPV16 3.5% and with HPV18 1.0%. Age specific prevalence estimates were the highest among 20-24 years old women and decreased with age. HPV16 prevalence was lowest among women without evidence of cervical disease and increased with the severity to 41.9% in women with high grade squamous intraepithelial lesion. Our results provide baseline data for monitoring the impact of Slovenian HPV vaccination program and development of future cervical cancer screening strategies in cohorts eligible for free HPV vaccination. (C) 2011 Elsevier Ltd. All rights reserved.
机译:为了评估2010年筛查宫颈癌的20-64岁斯洛文尼亚女性中14种高危型人乳头瘤病毒(hr-HPV)宫颈疫苗的接种前患病率,我们连续登记了16例门诊妇科服务中的4431名女性。所有患者均用Digene Hybrid Capture 2 HPV DNA测试和雅培实时高风险HPV测试进行筛选,并对所有阳性样本进行基因分型。所检查的任何hr-HPV类型的宫颈感染患病率为12.9%,HPV16为3.5%,HPV18为1.0%。年龄特定患病率估算值在20-24岁女性中最高,并且随着年龄的增长而降低。在没有宫颈疾病证据的女性中,HPV16患病率最低,而在高度鳞状上皮内病变的女性中,HPV16患病率随着严重程度的增加而上升至41.9%。我们的结果提供了基线数据,用于监测斯洛文尼亚人HPV疫苗接种计划的影响以及未来有资格接受免费HPV疫苗接种的人群的子宫颈癌筛查策略的发展。 (C)2011 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号